LMR Partners’s Nuvation Bio NUVB Stock Holding History

LMR Partners’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-78,177	Closed	-$817K	–	1263
2021 Q1	$817K	Buy	+78,177	New	+$874K	0.02%	526

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

LMR Partners's NUVB Position: Q2 2021 in Review

LMR Partners sold out of Nuvation Bio (NUVB) in Q2 2021, closing a stake of 78,177 shares — an estimated $817K sold.

LMR Partners first reported a position in NUVB in Q1 2021 and held it in 1 quarter. The position peaked at $817K in Q1 2021. 99 funds tracked by Wall St. Rank hold NUVB as of Q2 2021.

LMR Partners reported no remaining Nuvation Bio position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 78,177 Nuvation Bio shares in Q2 2021, an estimated $817K.
LMR Partners first reported a position in Nuvation Bio in Q1 2021 and held it in 1 quarter.
LMR Partners's Nuvation Bio position peaked at $817K in Q1 2021.
99 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.